Arch Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Arch Technologies's estimated annual revenue is currently $2.5M per year.
- Arch Technologies's estimated revenue per employee is $101,500
Employee Data
- Arch Technologies has 25 Employees.
- Arch Technologies grew their employee count by 9% last year.
Arch Technologies's People
Name | Title | Email/Phone |
---|
Arch Technologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.2M | 63 | 0% | N/A | N/A |
#2 | $3.8M | 33 | -33% | N/A | N/A |
#3 | $293.3M | 1445 | -12% | N/A | N/A |
#4 | $1.7M | 19 | -17% | N/A | N/A |
#5 | $13.1M | 90 | -11% | N/A | N/A |
#6 | $6.7M | 51 | 38% | N/A | N/A |
#7 | $14.1M | 97 | 3% | N/A | N/A |
#8 | $5.1M | 44 | 47% | N/A | N/A |
#9 | $16.7M | 115 | -78% | N/A | N/A |
#10 | $23.3M | 146 | 26% | N/A | N/A |
What Is Arch Technologies?
SAP @ ARCH We deliver SAP CX, S4HANA, MDG & SAC solutions and integrations aligned with Customer's digital needs. Our end to end advisory, consulting, implementation and support services for SAP Solutions will ensure you reap maximum benefits from your investment. We support organizations by their Digital Customer Experience (CX) transformation. We are successful because of we herein:
keywords:N/AN/A
Total Funding
25
Number of Employees
$2.5M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Arch Technologies News
FDA approves Thoraflex Hybrid device for complex aortic arch disease ... Aortic arch stenting: current strategies, new technologies and...
The CEO lauded the execution on Intel's multi-generation roadmap for its Xe high-performance GPUs, spinning it as a pivotal technology for the...
Integrating comfort technologies from Skechers' award-winning running and ... Skechers Arch Fit Technology is a removable insole system...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.3M | 25 | -11% | N/A |
#2 | $4.4M | 25 | -4% | N/A |
#3 | $2.6M | 25 | -17% | N/A |
#4 | $2.9M | 25 | N/A | N/A |
#5 | $2.5M | 25 | N/A | N/A |